Mahmoud Mahmoud Ibrahim

Mahmoud Mahmoud Ibrahim

Auto-generated profile, based on publicly available information

Mahmoud Mahmoud Ibrahim

McLaren Health Care

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
KAKerollos Abdelsayed
Kerollos Abdelsayed
BABasma Ehab Amer
Basma Ehab Amer
AMAhmed Almahdy Mohamed
Ahmed Almahdy Mohamed
MFMichele Fouad
Michele Fouad
AAAhmed Mazen Amin
Ahmed Mazen Amin
Azeem LatibAzeem Latib
Azeem Latib
Background: Conduction disturbances are frequent complications following transcatheter aortic valve intervention (TAVI), partially driven by inflammation. The anti‐inflammatory role of colchicine on these disorders post TAVI has not been studied yet. Therefore, we investigated the association between preoperative colchicine use and conduction disturbances after TAVI. Methods: We used the TriNetX platform, a data repository of health record data from health care organizations in the United States, to identify patients receiving any colchicine prescription within 3 months before their first TAVI and compared them to propensity score matched patients never exposed to colchicine up to 1 year after the procedure. Primary outcomes included new‐onset or worsening atrioventricular or left bundle‐branch block (LBBB) and heart block (HB) postoperatively. Outcomes were assessed within 1 and 6 months after TAVI with an E‐sensitivity analysis assessing the impact of unmeasured confounders. Results: Of 52 860 patients, 705 were on preoperative colchicine. After matching, each group included 702 patients. Colchicine was associated with a statistically significant reduction of new‐onset or worsening atrioventricular/left bundle‐branch block and heart block post TAVI at 1 month (relative risk [RR], 0.867 [95% CI, 0.756–0.994], P =0.041; RR, 0.887 [95% CI, 0.788–0.999], P =0.047, respectively) but not at 6 months (RR, 0.886 [95% CI, 0.779–1.077], P =0.064; RR, 0.913 [95% CI, 0.817–1.020], P =0.109, respectively). The E‐value was >1.5 for the statistically significant outcomes. Conclusions: Preoperative colchicine was associated with a lower incidence of new‐onset or worsening atrioventricular/left bundle‐branch block and heart block after TAVI at 1 month. However, no significant difference was observed at 6 months. Future prospective studies are needed to evaluate the definitive role of colchicine in improving TAVI outcomes.

18 May 2026 in Baylor University Medical Center Proceedings
Verified
Journal Article
Open access
AAAhmed Mazen Amin
Ahmed Mazen Amin
WSWafaa Shehada
Wafaa Shehada
MEMohamed Elgebaly
Mohamed Elgebaly
DADina Ayman
Dina Ayman
MIMahmoud Mahmoud Ibrahim
Mahmoud Mahmoud Ibrahim
KFKevin Felpel
Kevin Felpel
Patients with hypertrophic cardiomyopathy (HCM) are generally restricted from exercising. We aimed to investigate the effects of exercise on cardiorespiratory fitness, cardiac structure, cardiac function, and clinical safety for patients with HCM. We performed a systematic review and meta-analysis by searching PubMed, Web of Science, Scopus, Embase, and CENTRAL up to April 2025. Dichotomous outcomes were pooled using risk ratios (RRs), while continuous outcomes were pooled using mean differences (MDs) or standardized mean differences (SMDs), all with 95% confidence intervals (CIs), using R version 4.3.1. With the inclusion of seven studies—three randomized controlled trials and four observational studies—our cohort comprised 9702 patients. Compared to the control group, exercise was significantly associated with increased cardiorespiratory fitness (peak oxygen consumption [peak VO2] (mL∙kg−1∙min−1) (MD: 1.78; 95% CI [0.98, 2.59]; P < 0.01) and VO2 at an anaerobic threshold (mL∙kg−1∙min−1) (MD: 1.27; 95% CI [0.34, 2.20]; P < 0.01), reduced body mass index (kg/m2) (MD: −0.67; 95% CI [−1.17, −0.18]; P < 0.01), reduced left ventricular wall thickness (mm) measured by echocardiography (MD: −0.56; 95% CI [−1.01, −0.11]; P = 0.01), increased quality of life physical factor (SMD: 0.66; 95% CI [0.34, 0.97]; P < 0.01), and decreased incidence of all-cause mortality (RR: 0.71; 95% CI [0.60, 0.85]; P < 0.01). This study suggests that structured exercise interventions are safe and associated with improvements in cardiorespiratory fitness, left ventricular wall thickness, body mass index, and quality of life physical factor in patients with HCM, without increasing the risk of arrhythmias. Although a lower mortality rate was observed, this finding was mainly driven by observational studies and should therefore be interpreted with caution. Larger randomized controlled trials are needed to confirm these findings.

11 April 2023
Verified
Preprint
Open access
PDF file
ASAmith Seri
Amith Seri
MIMahmoud Ibrahim
Mahmoud Ibrahim
FTFahimeh Talaei
Fahimeh Talaei
MHMustafa Hassan
Mustafa Hassan
Well known adverse effects of cryoablation are phrenic nerve and esophageal injury. (1, 2) However, there is very little literature about coronary artery spasm (CAS), a life-threatening complication of cryoablation. We report a case of a 68-year-old Caucasian female, who developed left main coronary spasm (CAS) with significant hemodynamic compromise during cryoablation. Although rare, this complication can be life threatening. Prompt recognition and appropriate intervention is critical for good patient outcome.